Google News

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues - Reuters

Sep 18, 2026, 11:59 PM

Translate article text

Choose a language and wait for the translated text.

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues  Reuters